Andere Sprachen GemVax&KAEL Co.,Ltd.

Aktien

A082270

KR7082270000

A082270

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 12.06.2024			% 5 Tage	% 1. Jan.
10.940 ^KRW	+0,09 %		-6,50 %	-17,62 %

2022	GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) gibt einen Aktienrückkauf von 150.000 Aktien bekannt.	CI
2022	GemVax&KAEL Co.,Ltd genehmigt einen Rückkaufplan.	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	02.05.
GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	25.03.
GemVax&KAEL Co.,Ltd. announced that it expects to receive KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	21.03.
Gemvaxlink Co., Ltd. announced that it has received KRW 29.099978456 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd and other investors	18.03.
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on June 14, 2022.	31.08.22
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 150,000 shares.	14.06.22
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	14.06.22
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on April 13, 2022.	13.06.22
GemVax&KAEL Co.,Ltd's Equity Buyback announced on April 13, 2022, has closed with 300,000 shares, representing 0.76% for KRW 4,333.75 million.	10.06.22
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 300,000 shares.	13.04.22
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	13.04.22
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) added to S&P Global BMI Index	20.09.21
GemVax&KAEL Co.,Ltd acquired additional 12.9% stake in Gemvaxlink Co., Ltd. for KRW 18 billion.	19.08.21
GemVax&KAEL Co.,Ltd acquired additional 12.99% stake in Gemvaxzio Co., Ltd. for KRW 18.02 billion.	19.08.21
Gemvax & Kael : highly promising Phase II Alzheimer's disease clinical trial results targeting telomerase published in prestigious Alzheimer's Research & Therapy' journal	30.03.21
GemVax's Highly Promising Phase II Alzheimer's Disease Clinical Trial Results Targeting Telomerase Published in Alzheimer's Research & Therapy' Journal	30.03.21
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) dropped from S&P Global BMI Index	22.03.21
GemVax & KAEL Announces the Decision to Apply for an Expanded Access IND for Its Lead Candidate GV1001 to Include Additional Investigational Groups in Alzheimer's	06.10.20
Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	18.06.20
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	10.06.20

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen GemVax&KAEL Co.,Ltd.

Aktien

A082270

KR7082270000

A082270

Andere Sprachen

Filter